Table 3.
Potentially inappropriate medication prescribing identified by the STOPP criteria
| Criterion | N (%) |
|---|---|
| Any duplicate drug class prescription | 5 (3.4) |
| Calcium channel blockers | 5 (3.4) |
| Cardiovascular system | 15 (10.3) |
| Loop diuretic as first-line treatment | 11 (7.5) |
| Centrally acting antihypertensives | 4 (2.7) |
| Central nervous system | 17 (11.6) |
| Phenothiazines | 1 (0.7) |
| First-generation antihistamines | 16 (11.0) |
| Respiratory system | 3 (2.0) |
| Antimuscarinic bronchodilators with a history of bladder outflow obstruction | 3 (2.0) |
| Genitourinary system | 2 (1.4) |
| Antimuscarinic drugs for chronic prostatism | 2 (1.4) |
| Endocrine system | 3 (2.0) |
| Sulphonylureas with a long duration of action | 3 (2.0) |
| Drugs that predictably increase the risk of falls in older people | 16 (11.0) |
| Benzodiazepines | 12 (8.2) |
| Neuroleptic drugs | 4 (2.7) |
| Antimuscarinic/anticholinergic drug burden | 85 (58.2) |
STOPP Screening Tool of Older Persons’ Prescriptions